Reversing the biomechanical dysregulation of cancer cell signalling to improve targeted therapies
Reversing the biomechanical dysregulation of cancer cell signalling to improve targeted therapies
批准号:
nhmrc : 1129766
负责人:
金额:
$45.28万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2019-12-31
中文摘要
抗癌药物的有限成功取决于许多因素,包括肿瘤的物理特性(僵硬)。特别是,肿瘤是软的还是硬的会影响它对治疗的反应。将经典生物学与工程学相结合,生成模拟肿瘤的3D模型,以及尖端成像技术,我们将确定如何将肿瘤的物理属性与已经批准的抗癌药物一起靶向,以改善治疗和患者结果。
英文摘要
The limited success of cancer drugs is dependent on many factors including the physical properties (stiffness) of a tumour. In particular whether a tumour is soft or stiff affects how it responds to treatment. Combining classical biology with engineering to generate 3D models that mimic tumours, along with cutting-edge imaging technology, we will determine how we can target the physical properties of tumours together with already approved cancer drugs to improve treatment and patient outcome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金